It’s not easy to transplant a whole human eye. The surgery is difficult. And the eyes themselves start to degenerate as soon as they’ve left the body. When surgeons attempted it a few years ago, the newly-transplanted eye wasn’t able to see. But researchers believe they might have a solution: a device that maintains and…
Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.
SpaceX has finally made the contents of its IPO filing public, weeks ahead of what is expected to be the largest IPO ever and one that will make Musk the CEO, CTO, and Chairman of the board.
Most organizations think they have an AI execution problem, but the real issue is leadership hesitation around tradeoffs, ownership and the willingness to decide what actually matters.
Learn why the smartest founders are replacing traditional marketers with “Narritects” who bring clarity, consistency and strategic storytelling back to the center of growth.